vs

Side-by-side financial comparison of AvalonBay Communities (AVB) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $767.9M, roughly 1.9× AvalonBay Communities). AvalonBay Communities runs the higher net margin — 9040.6% vs 27.6%, a 9013.0% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs 3.7%). Over the past eight quarters, ResMed's revenue compounded faster (7.8% CAGR vs 3.8%).

AvalonBay Communities, Inc. is a publicly traded real estate investment trust that invests in apartments.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

AVB vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.9× larger
RMD
$1.4B
$767.9M
AVB
Growing faster (revenue YoY)
RMD
RMD
+7.3% gap
RMD
11.0%
3.7%
AVB
Higher net margin
AVB
AVB
9013.0% more per $
AVB
9040.6%
27.6%
RMD
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.8%
3.8%
AVB

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
AVB
AVB
RMD
RMD
Revenue
$767.9M
$1.4B
Net Profit
$166.0M
$392.6M
Gross Margin
61.8%
Operating Margin
64.2%
34.6%
Net Margin
9040.6%
27.6%
Revenue YoY
3.7%
11.0%
Net Profit YoY
-41.2%
13.9%
EPS (diluted)
$1.18
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVB
AVB
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.4B
Q4 25
$767.9M
$1.4B
Q3 25
$766.8M
$1.3B
Q2 25
$760.2M
$1.3B
Q1 25
$745.9M
$1.3B
Q4 24
$740.5M
$1.3B
Q3 24
$734.3M
$1.2B
Net Profit
AVB
AVB
RMD
RMD
Q2 26
$392.6M
Q1 26
$398.7M
Q4 25
$166.0M
$392.6M
Q3 25
$381.3M
$348.5M
Q2 25
$268.7M
$379.7M
Q1 25
$236.6M
$365.0M
Q4 24
$282.1M
$344.6M
Q3 24
$372.5M
$311.4M
Gross Margin
AVB
AVB
RMD
RMD
Q2 26
61.8%
Q1 26
62.2%
Q4 25
61.8%
Q3 25
61.5%
Q2 25
60.8%
Q1 25
59.3%
Q4 24
58.6%
Q3 24
58.6%
Operating Margin
AVB
AVB
RMD
RMD
Q2 26
34.6%
Q1 26
34.9%
Q4 25
64.2%
34.6%
Q3 25
65.7%
33.4%
Q2 25
67.6%
33.7%
Q1 25
68.5%
33.0%
Q4 24
63.1%
32.5%
Q3 24
65.4%
31.6%
Net Margin
AVB
AVB
RMD
RMD
Q2 26
27.6%
Q1 26
27.9%
Q4 25
9040.6%
27.6%
Q3 25
49.7%
26.1%
Q2 25
35.3%
28.2%
Q1 25
31.7%
28.3%
Q4 24
38.1%
26.9%
Q3 24
50.7%
25.4%
EPS (diluted)
AVB
AVB
RMD
RMD
Q2 26
$2.68
Q1 26
$2.74
Q4 25
$1.18
$2.68
Q3 25
$2.68
$2.37
Q2 25
$1.88
$2.58
Q1 25
$1.66
$2.48
Q4 24
$1.99
$2.34
Q3 24
$2.61
$2.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVB
AVB
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$187.2M
$1.4B
Total DebtLower is stronger
$9.3B
$663.8M
Stockholders' EquityBook value
$11.6B
$6.3B
Total Assets
$22.2B
$8.5B
Debt / EquityLower = less leverage
0.80×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVB
AVB
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.7B
Q4 25
$187.2M
$1.4B
Q3 25
$123.3M
$1.4B
Q2 25
$102.8M
$1.2B
Q1 25
$53.3M
$932.7M
Q4 24
$108.6M
$521.9M
Q3 24
$552.4M
$426.4M
Total Debt
AVB
AVB
RMD
RMD
Q2 26
$663.8M
Q1 26
$664.1M
Q4 25
$9.3B
$403.9M
Q3 25
$8.7B
$408.7M
Q2 25
$8.7B
$658.4M
Q1 25
$8.3B
$663.1M
Q4 24
$8.1B
$662.9M
Q3 24
$8.4B
$667.6M
Stockholders' Equity
AVB
AVB
RMD
RMD
Q2 26
$6.3B
Q1 26
$6.5B
Q4 25
$11.6B
$6.3B
Q3 25
$11.9B
$6.1B
Q2 25
$11.9B
$6.0B
Q1 25
$11.9B
$5.5B
Q4 24
$11.9B
$5.3B
Q3 24
$11.9B
$5.2B
Total Assets
AVB
AVB
RMD
RMD
Q2 26
$8.5B
Q1 26
$8.8B
Q4 25
$22.2B
$8.5B
Q3 25
$21.9B
$8.3B
Q2 25
$21.8B
$8.2B
Q1 25
$21.2B
$7.6B
Q4 24
$21.0B
$7.1B
Q3 24
$21.3B
$7.2B
Debt / Equity
AVB
AVB
RMD
RMD
Q2 26
0.11×
Q1 26
0.10×
Q4 25
0.80×
0.06×
Q3 25
0.73×
0.07×
Q2 25
0.72×
0.11×
Q1 25
0.70×
0.12×
Q4 24
0.68×
0.13×
Q3 24
0.70×
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVB
AVB
RMD
RMD
Operating Cash FlowLast quarter
$1.7B
Free Cash FlowOCF − Capex
$1.4B
FCF MarginFCF / Revenue
183.5%
Capex IntensityCapex / Revenue
34.1%
Cash ConversionOCF / Net Profit
10.07×
TTM Free Cash FlowTrailing 4 quarters
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVB
AVB
RMD
RMD
Q2 26
Q1 26
Q4 25
$1.7B
$339.7M
Q3 25
$477.0M
$457.3M
Q2 25
$377.8M
$538.8M
Q1 25
$415.9M
$578.7M
Q4 24
$1.6B
$308.6M
Q3 24
$486.2M
$325.5M
Free Cash Flow
AVB
AVB
RMD
RMD
Q2 26
Q1 26
Q4 25
$1.4B
$311.2M
Q3 25
$402.2M
$414.4M
Q2 25
$317.1M
$508.2M
Q1 25
$367.5M
$557.9M
Q4 24
$1.4B
$288.0M
Q3 24
$434.2M
$307.7M
FCF Margin
AVB
AVB
RMD
RMD
Q2 26
Q1 26
Q4 25
183.5%
21.9%
Q3 25
52.5%
31.0%
Q2 25
41.7%
37.7%
Q1 25
49.3%
43.2%
Q4 24
191.0%
22.5%
Q3 24
59.1%
25.1%
Capex Intensity
AVB
AVB
RMD
RMD
Q2 26
Q1 26
Q4 25
34.1%
2.0%
Q3 25
9.8%
3.2%
Q2 25
8.0%
2.3%
Q1 25
6.5%
1.6%
Q4 24
26.1%
1.6%
Q3 24
7.1%
1.5%
Cash Conversion
AVB
AVB
RMD
RMD
Q2 26
Q1 26
Q4 25
10.07×
0.87×
Q3 25
1.25×
1.31×
Q2 25
1.41×
1.42×
Q1 25
1.76×
1.59×
Q4 24
5.70×
0.90×
Q3 24
1.31×
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons